BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

136 related articles for article (PubMed ID: 38579649)

  • 61. Economic burden of low physical activity and high sedentary behaviour in Finland.
    Kolu P; Kari JT; Raitanen J; Sievänen H; Tokola K; Havas E; Pehkonen J; Tammelin TH; Pahkala K; Hutri-Kähönen N; Raitakari OT; Vasankari T
    J Epidemiol Community Health; 2022 Jul; 76(7):677-684. PubMed ID: 35473717
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Socioeconomic costs of overweight and obesity in Korean adults.
    Kang JH; Jeong BG; Cho YG; Song HR; Kim KA
    J Korean Med Sci; 2011 Dec; 26(12):1533-40. PubMed ID: 22147988
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Current estimates of the economic cost of obesity in the United States.
    Wolf AM; Colditz GA
    Obes Res; 1998 Mar; 6(2):97-106. PubMed ID: 9545015
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Healthcare Costs Associated with an Adequate Intake of Sugars, Salt and Saturated Fat in Germany: A Health Econometrical Analysis.
    Meier T; Senftleben K; Deumelandt P; Christen O; Riedel K; Langer M
    PLoS One; 2015; 10(9):e0135990. PubMed ID: 26352606
    [TBL] [Abstract][Full Text] [Related]  

  • 65. The economic burden of physical inactivity: a global analysis of major non-communicable diseases.
    Ding D; Lawson KD; Kolbe-Alexander TL; Finkelstein EA; Katzmarzyk PT; van Mechelen W; Pratt M;
    Lancet; 2016 Sep; 388(10051):1311-24. PubMed ID: 27475266
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Forecasting the future economic burden of current adolescent overweight: an estimate of the coronary heart disease policy model.
    Lightwood J; Bibbins-Domingo K; Coxson P; Wang YC; Williams L; Goldman L
    Am J Public Health; 2009 Dec; 99(12):2230-7. PubMed ID: 19833999
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Economic costs of diabetes in the US in 2002.
    Hogan P; Dall T; Nikolov P;
    Diabetes Care; 2003 Mar; 26(3):917-32. PubMed ID: 12610059
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Economic costs of diabetes in the U.S. In 2007.
    American Diabetes Association
    Diabetes Care; 2008 Mar; 31(3):596-615. PubMed ID: 18308683
    [TBL] [Abstract][Full Text] [Related]  

  • 69. The household economic burden of non-communicable diseases in 18 countries.
    Murphy A; Palafox B; Walli-Attaei M; Powell-Jackson T; Rangarajan S; Alhabib KF; Avezum AJ; Calik KBT; Chifamba J; Choudhury T; Dagenais G; Dans AL; Gupta R; Iqbal R; Kaur M; Kelishadi R; Khatib R; Kruger IM; Kutty VR; Lear SA; Li W; Lopez-Jaramillo P; Mohan V; Mony PK; Orlandini A; Rosengren A; Rosnah I; Seron P; Teo K; Tse LA; Tsolekile L; Wang Y; Wielgosz A; Yan R; Yeates KE; Yusoff K; Zatonska K; Hanson K; Yusuf S; McKee M
    BMJ Glob Health; 2020; 5(2):e002040. PubMed ID: 32133191
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Economic Costs of Diabetes in the U.S. in 2022.
    Parker ED; Lin J; Mahoney T; Ume N; Yang G; Gabbay RA; ElSayed NA; Bannuru RR
    Diabetes Care; 2024 Jan; 47(1):26-43. PubMed ID: 37909353
    [TBL] [Abstract][Full Text] [Related]  

  • 71. The projected economic and health burden of sub-optimal asthma control in Canada.
    Zafari Z; Sadatsafavi M; Chen W; FitzGerald JM
    Respir Med; 2018 May; 138():7-12. PubMed ID: 29724396
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Cost of disorders of the brain in Europe 2010.
    Gustavsson A; Svensson M; Jacobi F; Allgulander C; Alonso J; Beghi E; Dodel R; Ekman M; Faravelli C; Fratiglioni L; Gannon B; Jones DH; Jennum P; Jordanova A; Jönsson L; Karampampa K; Knapp M; Kobelt G; Kurth T; Lieb R; Linde M; Ljungcrantz C; Maercker A; Melin B; Moscarelli M; Musayev A; Norwood F; Preisig M; Pugliatti M; Rehm J; Salvador-Carulla L; Schlehofer B; Simon R; Steinhausen HC; Stovner LJ; Vallat JM; Van den Bergh P; van Os J; Vos P; Xu W; Wittchen HU; Jönsson B; Olesen J;
    Eur Neuropsychopharmacol; 2011 Oct; 21(10):718-79. PubMed ID: 21924589
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Economic burden of insomnia symptoms in Canada.
    Chaput JP; Janssen I; Sampasa-Kanyinga H; Carney CE; Dang-Vu TT; Davidson JR; Robillard R; Morin CM
    Sleep Health; 2023 Apr; 9(2):185-189. PubMed ID: 36319579
    [TBL] [Abstract][Full Text] [Related]  

  • 74. The humanistic and economic burden of atopic dermatitis among adults and adolescents in Saudi Arabia.
    Elezbawy B; Fasseeh AN; Fouly E; Esba LCA; Al Abdulkarim H; Al-Haddab M; Al-Sheikh A; Altawil E; Al Turaiki A; Eshmawi M; Hamadah I; Tannira M; Dalle H; Aderian S; Roshdy A; Jaheen A; Hamad T; Abaza S; Kaló Z
    J Med Econ; 2022; 25(1):1231-1239. PubMed ID: 36426726
    [TBL] [Abstract][Full Text] [Related]  

  • 75. The Economic Burden of Adults with Major Depressive Disorder in the United States (2019).
    Greenberg P; Chitnis A; Louie D; Suthoff E; Chen SY; Maitland J; Gagnon-Sanschagrin P; Fournier AA; Kessler RC
    Adv Ther; 2023 Oct; 40(10):4460-4479. PubMed ID: 37518849
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Direct cost of systemic arterial hypertension and its complications in the circulatory system from the perspective of the Brazilian public health system in 2019.
    Curado DDSP; Gomes DF; Silva TBC; Almeida PHRF; Tavares NUL; Areda CA; da Silva EN
    PLoS One; 2021; 16(6):e0253063. PubMed ID: 34111216
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Impact of implementation of front-of-package nutrition labeling on sugary beverage consumption and consequently on the prevalence of excess body weight and obesity and related direct costs in Brazil: An estimate through a modeling study.
    Faria NC; Andrade GMP; Ruas CM; Claro RM; Braga LVM; Nilson EAF; Anastácio LR
    PLoS One; 2023; 18(8):e0289340. PubMed ID: 37566577
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Obesity prevalence in Mexico: impact on health and economic burden.
    Rtveladze K; Marsh T; Barquera S; Sanchez Romero LM; Levy D; Melendez G; Webber L; Kilpi F; McPherson K; Brown M
    Public Health Nutr; 2014 Jan; 17(1):233-9. PubMed ID: 23369462
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Modeling the Health and Economic Burden of Chronic Obstructive Pulmonary Disease in China From 2020 to 2039: A Simulation Study.
    Park JE; Zhang L; Ho YF; Liu G; Alfonso-Cristancho R; Ismaila AS; Zafari Z
    Value Health Reg Issues; 2022 Nov; 32():8-16. PubMed ID: 35961283
    [TBL] [Abstract][Full Text] [Related]  

  • 80. The direct and indirect costs of cardiovascular diseases in Brazil.
    de Araújo JM; Eufrosino de Alencar Rodrigues R; da Costa Pereira de Arruda Neta A; Leite Lima Ferreira FE; Lira Formiga Cavalcanti de Lima R; Pinheiro de Toledo Vianna R; Vasconcelos Leitão Moreira L; Moreira da Silva Neto J; Moreira PVL
    PLoS One; 2022; 17(12):e0278891. PubMed ID: 36548305
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.